CHRND Gene Myasthenic Syndrome Congenital Type 3A Slow Channel Genetic Test
Test Details:
The CHRND gene is associated with a type of congenital myasthenic syndrome called slow channel syndrome. This syndrome is characterized by muscle weakness and fatigue, which can be present from birth or develop in childhood.
NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously. In the context of slow channel syndrome, NGS genetic testing can be used to identify mutations or variations in the CHRND gene that may be responsible for the condition.
The test involves obtaining a DNA sample, usually through a blood sample or cheek swab, and then sequencing the DNA to identify any abnormalities in the CHRND gene. This can help in confirming a diagnosis of slow channel syndrome and determining the specific genetic variant causing the condition.
Genetic testing can be beneficial for individuals with suspected slow channel syndrome as it can provide a definitive diagnosis, guide treatment decisions, and help with genetic counseling and family planning. It is important to consult with a healthcare professional or genetic counselor to understand the implications and limitations of genetic testing.
Test Name: CHRND Gene Myasthenic Syndrome Congenital Type 3A Slow Channel Genetic Test
Components:
- Price: 4400.0 AED
Sample Condition:
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery:
3 to 4 Weeks
Method:
NGS Technology
Test Type:
Neurological Disorders
Doctor:
Neurologist
Test Department:
Genetics
Pre Test Information:
Clinical History of Patient who is going for CHRND Gene Myasthenic syndrome, congenital, type 3A, slow channel NGS Genetic DNA Test
A Genetic Counselling session to draw a pedigree chart of family members affected with CHRND Gene Myasthenic syndrome, congenital, type 3A, slow channel
Test Name | CHRND Gene Myasthenic syndrome congenital type 3A slow channel Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for CHRND Gene Myasthenic syndrome, congenital, type 3A, slow channel NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CHRND Gene Myasthenic syndrome, congenital, type 3A, slow channel |
Test Details |
The CHRND gene is associated with a type of congenital myasthenic syndrome called slow channel syndrome. This syndrome is characterized by muscle weakness and fatigue, which can be present from birth or develop in childhood. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously. In the context of slow channel syndrome, NGS genetic testing can be used to identify mutations or variations in the CHRND gene that may be responsible for the condition. The test involves obtaining a DNA sample, usually through a blood sample or cheek swab, and then sequencing the DNA to identify any abnormalities in the CHRND gene. This can help in confirming a diagnosis of slow channel syndrome and determining the specific genetic variant causing the condition. Genetic testing can be beneficial for individuals with suspected slow channel syndrome as it can provide a definitive diagnosis, guide treatment decisions, and help with genetic counseling and family planning. It is important to consult with a healthcare professional or genetic counselor to understand the implications and limitations of genetic testing. |